
Sep 2026
$150M
Series E
Platform Feature
Track ownership structures, funding histories, and competitive positioning across venture-backed companies. Surface insights institutional investors rely on.
Explore CompaniesSep 20, 2026
Companies Tracked
83,171
Total Funding
$15.3T
Investors
28,353
People
213,684
Companies Tracked
83,171
Countries Coverage
138
Data Points
36,194,599
Explore Companies
Premium insights on startups and enterprise tech developments
aVenture unlocks research to leading startups that outperform public markets. Schedule a free call with an aVenture research analyst to see how can help your with you and your firm.
Expert analysis on venture capital trends and investment strategies
Since 1984, venture funds have exhibited comparable risk to some public and private equity investments, while potentially offering better returns.
Since 2006, the number of deals and the capital raised have been growing exponentially, reaching a total of $164 billion invested across 11,651 deals in 2020 alone.
Annual VC Investment
$164B
Annual deployed venture capital investment in last measured year
Annual Investment Rounds
11,651
Number of VC funding rounds in most recent year
Growth Trend
+243% Increase
Number of annual VC investment rounds vs. 15 years ago
Venture capital investments over time

Source: NVCA, 2021. “NVCA 2021 Yearbook”, with underlying data provided by Pitchbook. Analysis period 2002-2020. The chart as displayed includes the total capital raised for each year in the VC asset class and the number of investments made by VC funds.
Get custom coverage for any company, sector, or market not yet in our database. We'll work with you to expand our research where you need it most.

GondolaBio
Palo Alto, CA, US
Founded
2024
Stage
Seed
Total Raised
$300M
Sarah Neville / Financial Times: Clinicians raise concerns over medical AI adoption beyond diagnostics and imaging, citing limited clinical and performance data on its broader effectiveness — The technology's advances have not yet translated into big improvements in real-life care. Kayla Secrest was
Sep 19, 2026

Sep 2026
$135M
Series B

Sep 2026
$45M
Series B

Sep 2026
$34M
Series A

Sep 2026
$18M
Series A

Sep 2026
$30M
Series B

Sep 2026
$3.9B
Series F

Sep 2026
$250M
Other
Source: Morgan Stanley (2020), "Public to Private Equity in the United States: A Long-Term Look". Past performance does not ensure future results and expected risk, returns, or other projections may not reflect future performance. All asset classes correspond to the period 1984-2015, except for venture capital funds, which reflect the period 1984-2013, representing the most recent data available at the time of the study publication.
Risk Level vs Other Equities
Comparable Risk Profile
Similar long-run standard deviation to small public companies
Returns
Best Risk Adjusted Returns
Well above average risk-adjusted returns of any asset class
New York, NY, US
Founded
2016
Stage
Seed
Total Raised
$1.2M
Los Angeles, CA, US
Founded
2021
Stage
Series B
Total Raised
$52.3M
GondolaBio
Palo Alto, CA, US
Founded
2024
Stage
Seed
Total Raised
$300M